Skp2B overexpression alters a prohibitin-p53 axis and the transcription of PAPP-A, the protease of insulin-like growth factor binding protein 4

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Chander, Harish ^a   Halpern, Max ^a   Resnick Silverman, Lois ^a   Manfredi, James J ^a   Germain, Doris ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROHIBITIN; PROTEIN P53; S PHASE KINASE ASSOCIATED PROTEIN 2; S PHASE KINASE ASSOCIATED PROTEIN 2B; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 4; UNCLASSIFIED DRUG; MESSENGER RNA; REPRESSOR PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN;

ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; HALF LIFE TIME; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN FOLDING; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TUMOR CELL LINE; WESTERN BLOTTING;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; HALF-LIFE; HUMANS; IMMUNOPRECIPITATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; MICE; MICE, TRANSGENIC; MUTATION; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROTEIN BINDING; PROTEIN FOLDING; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79961164621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022456     Document Type: Article

References (35)

1. Radke S, Pirkmaier A, Germain D, (2005) Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer. Oncogene 24: 3448-3458.
2. Umanskaya K, Radke S, Chander H, Monardo R, Xu X, et al. (2007) Skp2B stimulates mammary gland development by inhibiting REA, the repressor of the estrogen receptor. Mol Cell Biol 27: 7615-7622.
3. Mussi P, Liao L, Park SE, Ciana P, Maggi A, et al. (2006) Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland. Proc Natl Acad Sci U S A 103: 16716-16721.
4. Chander H, Halpern M, Resnick-Silverman L, Manfredi JJ, Germain D, (2010) Skp2B attenuates p53 function by inhibiting prohibitin. EMBO reports 11: 222-225.
5. Steglich G, Neupert W, Langer T, (1999) Prohibitins regulate membrane protein degradation by the m-AAA protease in mitochondria. Mol Cell Biol 19: 3435-3442.
6. Nijtmans LG, de Jong L, Artal Sanz M, Coates PJ, Berden JA, et al. (2000) Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. Embo J 19: 2444-2451.
7. Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S, (2003) Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 278: 47853-47861.
8. Rastogi S, Joshi B, Fusaro G, Chellappan S, (2006) Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism. J Biol Chem 281: 2951-2959.
9. Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup-Jensen L, et al. (2001) Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504: 36-40.
10. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, et al. (1999) The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A 96: 3149-3153.
11. Butler JS, Loh SN, (2006) Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature. Protein Sci 15: 2457-2465.
12. Powers MV, Workman P, (2006) Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors. Endocr Relat Cancer 13 (Suppl 1): S125-135.
13. Lin TM, Galbert SP, Kiefer D, Spellacy WN, Gall S, (1974) Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol 118: 223-236.
14. Gannon JV, Greaves R, Iggo R, Lane DP, (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. Embo J 9: 1595-1602.
15. Bargonetti J, Manfredi JJ, Chen X, Marshak DR, Prives C, (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev 7: 2565-2574.
16. Werner H, Karnieli E, Rauscher FJ, LeRoith D, (1996) Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A 93: 8318-8323.
17. Zalcenstein A, Stambolsky P, Weisz L, Muller M, Wallach D, et al. (2003) Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene 22: 5667-5676.
18. Yang X, Pater A, Tang SC, (1999) Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants. Oncogene 18: 4546-4553.
19. Pugacheva EN, Ivanov AV, Kravchenko JE, Kopnin BP, Levine AJ, et al. (2002) Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil. Oncogene 21: 4595-4600.
20. Brosh R, Rotter V, (2009) When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 9: 701-713.
21. Di Agostino S, Strano S, Emiliozzi V, Zerbini V, Mottolese M, et al. (2006) Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell 10: 191-202.
22. Graunke DM, Fornace AJ Jr, Pieper RO, (1999) Presetting of chromatin structure and transcription factor binding poise the human GADD45 gene for rapid transcriptional up-regulation. Nucleic Acids Res 27: 3881-3890.
23. Chin PL, Momand J, Pfeifer GP, (1997) In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation. Oncogene 15: 87-99.
24. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, et al. (1993) Analysis of the mammalian gadd45 gene and its response to DNA damage. J Biol Chem 268: 24385-24393.
25. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, et al. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649.
26. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100: 8418-8423.
27. Kobayashi S, (2008) Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance. Breast Cancer 15: 153-158.
28. Kuhajda FP, Eggleston JC, (1985) Pregnancy-associated plasma protein A. A clinically significant predictor of early recurrence in stage I breast carcinoma is independent of estrogen receptor status. Am J Pathol 121: 342-348.
29. Kuhajda FP, Eggleston JC, (1985) Pregnancy-associated plasma protein A and extensive necrosis. Clinically significant predictors of early recurrence in stage I estrogen receptor-negative breast carcinoma. Lab Invest 53: 101-107.
30. Bulut I, Coskun A, Ciftci A, Cetinkaya E, Altiay G, et al. (2009) Relationship Between Pregnancy-Associated Plasma Protein-A and Lung Cancer. Am J Med Sci 337: 241-244.
31. Tanaka Y, Kobayashi H, Suzuki M, Hirashima Y, Kanayama N, et al. (2004) Genetic downregulation of pregnancy-associated plasma protein-A (PAPP-A) by bikunin reduces IGF-I-dependent Akt and ERK1/2 activation and subsequently reduces ovarian cancer cell growth, invasion and metastasis. Int J Cancer 109: 336-347.
32. Marshman E, Streuli CH, (2002) Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function. Breast Cancer Res 4: 231-239.
33. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
34. Espinosa JM, Emerson BM, (2001) Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 8: 57-69.
35. Janus F, Albrechtsen N, Knippschild U, Wiesmuller L, Grosse F, et al. (1999) Different regulation of the p53 core domain activities 3′-to-5′ exonuclease and sequence-specific DNA binding. Mol Cell Biol 19: 2155-2168.